Laurie Adami built her career in financial technology and enterprise software, where precision and systems thinking were the tools of the trade. She brought that same instinct to twelve years as a cancer patient - navigating relapse after relapse, clinical trials, and the American healthcare system - all the while noting what she found: gaps, delays, and structural failures that every patient around her recognized.

When a CAR-T cell therapy trial at UCLA led to her remission, it was not just a medical turning point, it was the moment she could step back from surviving and begin speaking for others going through the same terrain.

Her leadership is shaped by both professional experience and her personal journey. She serves on boards advancing cancer research, patient advocacy, and global access to care.

Through talks, articles, and podcasts she has built an audience that knows her as a reliable, clear-eyed guide to what serious illness actually looks like from the inside.

The memoir she is writing has already drawn interest from healthcare partners who see it as a resource for patients, clinicians, and administrators trying to understand the full human complexity of treatments like CAR-T. Not just the science, but what it takes to get there.